Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kafr El Sheikh Pharmaceutical Industries (KSP) is an Egyptian pharmaceutical manufacturing company headquartered in the Kafr El Sheikh governorate. Established to address the growing demand for high-quality generic medicines in Egypt and the Middle East, the company operates a state-of-the-art facility in the Baltim Industrial Zone. KSP specializes in the production of various dosage forms, including tablets, capsules, and liquid orals, covering therapeutic areas such as anti-infectives, gastroenterology, and cardiology. The company emphasizes compliance with international Good Manufacturing Practice (GMP) standards and focuses on expanding its portfolio of essential generic drugs for both domestic and export markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on kafreelsheikh.